Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2014-01-31 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
First RayStation® order in the United Kingdom
Regulatory Filings Classification · 94% confidence The document is a press release dated January 31, 2014, announcing a specific business event: the first order for the RayStation® treatment planning system in the United Kingdom by Tayside Cancer Centre. This announcement details a significant business contract/sale, which falls under general corporate news or a specific business update rather than a mandatory regulatory filing like a 10-K, ER, or IR. It is not a management change (MANG), dividend notice (DIV), or capital structure change (CAP). Since it is a specific announcement of a business transaction/contract win, and there isn't a perfect fit for 'Contract Award' or 'Sales Update', the most appropriate general category among the provided options is 'Regulatory Filings' (RNS) as a catch-all for significant, non-standard announcements, or potentially 'Capital/Financing Update' (CAP) if the contract is viewed as a major revenue driver, but RNS is safer for general press releases about business milestones. Given the options, and that this is a press release announcing a major customer win, RNS (Regulatory Filings/General Announcement) is the best fit as it is not a core financial report or specific corporate action listed.
2014-01-31 English
Dutch clinic selects RayStation®
Regulatory Filings Classification · 87% confidence The document is a press release dated December 23, 2013, announcing that RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from a Dutch clinic. This announcement details a specific business transaction (an order/sale) and provides context about the customer and the product. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is a specific business update that doesn't fit the definitions for AGM-R, MANG, DVA, DLST, DIRS, SR, FS, CGR, IRAT, LTR, TAR, MRQ, NAV, DIV, DEF 14A, RPA, SHA, or POS. Since it is a specific business announcement that doesn't fit the primary categories, and it is not a general regulatory filing fallback (RNS), the closest fit among the remaining options is 'Capital/Financing Update' (CAP) if the order implies significant revenue or a strategic partnership, or it could be considered a general business update. However, given the options, this is a specific business development announcement. It is not a Call Transcript (CT) or Investor Presentation (IP). Since it is a press release announcing a specific business win, and there is no better fit, it is most closely related to a general business update. Given the strict definitions, and noting that it is not a financing event (CAP), the most appropriate fallback for a specific, non-standard business announcement that isn't a formal report is the general 'Regulatory Filings' (RNS) category, as it is a public disclosure, although 'RPA' (Report Publication Announcement) is for announcing *other* reports. Since this is a direct announcement of a business event, and it doesn't fit the other specific categories, RNS serves as the best general disclosure category available.
2013-12-23 English
Nederländsk klinik väljer RayStation®
Regulatory Filings Classification · 92% confidence The document is a press release dated December 23, 2013, announcing that RaySearch Laboratories AB has received an order for its RayStation® planning system from a Dutch clinic (RIF). This is a commercial announcement detailing a specific business transaction (an order/sale) rather than a mandatory regulatory filing like a 10-K, an earnings report (ER), or a management change (MANG). Since it announces a significant business event—a new contract/sale—it fits best under a general business update or announcement category. Given the provided definitions, it is not a specific financial report, capital change, or director dealing. It is a general business update that doesn't perfectly align with the specific financial/regulatory codes. Therefore, the most appropriate fallback category is Regulatory Filings (RNS) for general announcements that don't fit elsewhere, although 'Capital/Financing Update' (CAP) is sometimes used broadly for major contracts, this is primarily a sales announcement. However, looking closely at the options, none perfectly capture a 'Sales Contract Announcement'. Since it is a press release announcing a specific business event (a major order), and it is not a formal regulatory filing like 10-K or a specific financial report, RNS (Regulatory Filings - general regulatory announcements and fallback) is the most suitable general category for non-standard corporate news releases.
2013-12-23 Swedish
RaySearch inleder samarbete med CNAO Foundation
Regulatory Filings Classification · 95% confidence The document is a press release dated December 20, 2013, announcing that RaySearch Laboratories has received an order for its RayStation® dose planning system from the CNAO Foundation in Italy. The content focuses on a specific business transaction (an order/sale) and its implications, rather than routine financial reporting (like 10-K, IR, or ER). It is not a management change (MANG), a director's trade (DIRS), or a dividend announcement (DIV). Since it details a significant business development, specifically a new contract/order, it best fits the 'Capital/Financing Update' (CAP) category if the order represents a major financing event, or more generally, a 'Regulatory Filing' (RNS) if it's a standard market announcement not covered elsewhere. Given the context of a major commercial order announcement, and lacking a specific category for 'New Contract Wins' or 'Sales Orders', it is most appropriately classified as a general 'Regulatory Filing' (RNS) as it is a material, non-financial disclosure, or potentially 'CAP' if the order value is significant enough to be considered a financing/capital event, though 'RNS' is safer for general material news. However, looking closely at the definitions, none perfectly capture a 'New Customer Order Announcement'. Since it is a press release announcing a significant business event (a major order), and it is not a formal financial report, it falls under the general regulatory announcement category, RNS.
2013-12-20 Swedish
RaySearch starts a new collaboration with CNAO Foundation
Regulatory Filings Classification · 95% confidence The document is a press release dated December 20, 2013, announcing a new collaboration and order for the RayStation® treatment planning system from CNAO Foundation. It details a business transaction (an order/sale) and provides background information on the technology and the involved parties. This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR), best fits the category for general business updates or regulatory announcements that don't fit elsewhere. Since it is a specific business development announcement (an order/collaboration) rather than a general regulatory filing, it is most closely aligned with a general announcement or potentially a Capital/Financing Update if it involved raising capital, but here it is a sales order. Given the options, and since it is a specific business development announcement that isn't a core financial report, it falls under the general 'Regulatory Filings' (RNS) as a catch-all for non-standard announcements, or potentially a 'Capital/Financing Update' (CAP) if interpreted broadly as a business win, but RNS is safer for press releases detailing specific operational news that isn't earnings or management change. However, looking closely at the definitions, none perfectly capture a 'Sales Order Press Release'. It is not an ER, IR, 10-K, MANG, DIRS, or DIV. It is a press release announcing a significant business event. In the absence of a 'Business Development' or 'Contract Award' code, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for a press release of this nature.
2013-12-20 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for RaySearch Laboratories AB covering the period 1 January to 30 September 2013. It contains comprehensive financial statements, including income statements, balance sheet summaries, and management commentary on business performance, strategic milestones, and market outlook. It is not an announcement of a report, but the report itself, containing substantive financial data. 9M 2013
2013-11-27 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.